CryoPort (CYRX)

• Market cap: $275M
• 1 day: -10.71%
• 5 days: -11.29%
• 1 month: 14.58%
• 3 months: -35.22%
• 6 months: -30.11%
• Year to date: -31.08%
• 1 year: -70.01%
• 5 years: -64.99%
• 10 years: 144.44%
• Sector: Industrials
• Industry: Integrated Freight & Logistics

About: CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Employees: 1,186

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

3,011% more call options, than puts

Call options by funds: $2.21M | Put options by funds: $71K

48% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 21

28% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 46

7% more funds holding

Funds holding: 150 [Q3] → 160 (+10) [Q4]

1.21% more ownership

Funds ownership: 94.55% [Q3] → 95.76% (+1.21%) [Q4]

3% less capital invested

Capital invested by funds: $378M [Q3] → $368M (-$10.3M) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $11 100% upside
• Avg. target: $12.33 124% upside
• High target: $15 173% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Roth MKM Richard Baldry 35% 1-year accuracy 7 / 20 met price target	173% upside $15	Buy Reiterated	1 Apr 2025
UBS John Sourbeer 33% 1-year accuracy 1 / 3 met price target	100% upside $11	Buy Maintained	1 Apr 2025
Needham David Saxon 35% 1-year accuracy 23 / 66 met price target	100% upside $11	Buy Reiterated	1 Apr 2025